Erik Thedéen said a different approach is needed as the U.S. and U.K. refused to implement the rules already set out.Policy, The Basel Committee, banks, Regulation, banking, NewsRead More

You might also be interested in reading FDA accepts Arrowhead’s NDA for plozasiran.